What Researchers Did
Researchers conducted a pilot study to evaluate the safety and efficacy of 1.5 ATA hyperbaric oxygen therapy (HBOT) in 16 military subjects with chronic blast-induced mild to moderate traumatic brain injury (TBI)/post-concussion syndrome (PCS) and post-traumatic stress disorder (PTSD).
What They Found
Subjects experienced reversible adverse events including middle ear barotrauma (5), transient symptom deterioration (4), and bronchospasm (1). Post-treatment testing showed significant improvements in full-scale IQ (+14.8 points; p<0.001), PCS symptoms (p=0.0002), and PTSD symptoms (p<0.001), alongside improvements in memory, attention, mood, and quality of life.
What This Means for Canadian Patients
This preliminary study suggests that hyperbaric oxygen therapy could potentially offer a new treatment option for Canadian military personnel and veterans suffering from chronic blast-induced TBI, PCS, and PTSD. However, further research is needed to confirm these benefits and establish optimal treatment protocols before widespread clinical application.
Canadian Relevance
This study has no direct Canadian connection as it was conducted with military subjects in another country.
Study Limitations
As a preliminary pilot study with a small sample size of 16 subjects, the findings require validation in larger, controlled trials.